細胞治療技術の世界市場レポート 2024

細胞治療技術の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には14.8%の年間複合成長率（CAGR）で86億2,000万米ドルに成長すると予想されます。予測される成長は、人口の高齢化、がん罹患率の増加、医薬品の研究開発支出の増加、細胞治療の進歩によって促進されます。主な動向には、製品の革新、先端技術の活用、新しい細胞療法の開発、製造への投資、パートナーシップの育成などが含まれます。

世界の細胞治療技術市場は、細胞ベースの調査に対する政府投資の増加により成長を遂げています。政府は、がんや心血管疾患（CVD）などを含むさまざまな病気の治療法の開発に焦点を当てた調査活動を支援するために資金を割り当てています。この投資傾向の一例は、幹細胞調査を専門とする研究センターであるカリフォルニア再生医療研究所（CIRM）の活動に見られます。 2022年5月、CIRMは咽頭がんの治療を目的とした細胞療法の臨床試験に資金提供するために1,100万米ドル以上を投資しました。この治療法が成功すれば、患者が放射線療法やそれに伴う副作用から逃れられる可能性があります。

がんの罹患率は、細胞治療技術市場の成長に寄与する重要な要因となっています。生きた細胞を薬として利用して病気を治療する細胞療法は、特にがん治療に応用する場合、体内の異常細胞を探し出して破壊するという免疫系の固有の能力を活用します。米国がん協会によると、2022年には米国で合計 190万人の新規がん患者と609,360人のがん死亡者が発生すると推定されており、これは毎日約1,670人が死亡していることに相当します。さらに、国際がん調査機関の予測によると、2040年までに年間新規がん症例数は2,950万人に増加し、がん関連死亡者数は1,640万人に達すると予想されています。がんの有病率の増加は、予測期間における細胞治療技術市場の成長の重要な推進力になると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の細胞治療技術市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 消耗品
• 装置
• システムとソフトウェア
• 世界の細胞治療技術市場、細胞タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• T細胞
• 幹細胞
• その他の細胞
• 世界の細胞治療技術市場、プロセス別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 細胞プロセシング
• 細胞、保管、流通、ハンドリング
• プロセスの監視と品質管理
• 世界の細胞治療技術市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• ライフサイエンス企業
• 研究機関

第7章 地域および国の分析

• 世界の細胞治療技術市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の細胞治療技術市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 細胞治療技術市場の競合情勢
• 細胞治療技術市場の企業プロファイル
  • Lonza Group AG
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Terumo Corporation
  • Danaher Corporation

第31章 その他の大手および革新的な企業

• Fresenius Medical Care AG &Co. KGaA
• Fujifilm Holdings Corporation
• Sartorius AG
• Becton Dickinson and Company
• Avantor Inc.
• Cellular Biomedicine Group
• CORESTEM
• Astellas Pharma Inc
• Anterogen Co. Ltd
• Arce Therapeutics
• CARsgen Therapeutics
• Huadong Medicine
• Co.Don AG
• AstraZeneca
• Neogene Therapeutics

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Cell therapy represents a treatment method involving the injection of active cells into a patient's body to address specific disorders, aiming to modify sets of cells for disease treatment. This technique involves modifying cells outside the body, derived either from the patient or a donor, and then reintroducing them into the patient's system.

The primary product categories encompass consumables, equipment, systems, and software. Consumables refer to items intended for depletion or use during regular application. They find application across various cell types such as T-cells, stem cells, and others. Processes within cell therapy technologies include cell processing, preservation, distribution, handling, process monitoring, and quality control. These technologies have diverse applications spanning life science companies, research institutes, and cell banks.

The cell therapy technologies market research report is one of a series of new reports from The Business Research Company that provides cell therapy technologies market statistics, including cell therapy technologies industry global market size, regional shares, competitors with a cell therapy technologies market share, detailed cell therapy technologies market segments, market trends, and opportunities, and any further data you may need to thrive in the cell therapy technologies industry. This cell therapy technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell therapy technologies market size has grown rapidly in recent years. It will grow from $4.29 billion in 2023 to $4.97 billion in 2024 at a compound annual growth rate (CAGR) of 15.8%. Historical growth can be attributed to several factors, including robust economic expansion in emerging markets, a rise in healthcare expenditure, increased government investments in cell-based research, and a heightened demand for personalized medicine.

The cell therapy technologies market size is expected to see rapid growth in the next few years. It will grow to $8.62 billion in 2028 at a compound annual growth rate (CAGR) of 14.8%. Forecasted growth is driven by an aging population, increased cancer prevalence, higher R&D spending in pharmaceuticals, and advancements in cell therapies. Major trends include innovating products, leveraging advanced tech, developing novel cell therapies, investing in manufacturing, and fostering partnerships.

The global cell therapy technologies market has experienced growth, driven by increasing government investments in cell-based research. Governments are allocating funds to support research activities focused on developing therapies for various diseases, including cancer, cardiovascular disease (CVD), and more. An example of this investment trend is observed in the actions of The California Institute for Regenerative Medicine (CIRM), a research center dedicated to stem cell research. In May 2022, CIRM invested over $11 million to fund a clinical trial for a cell therapy designed to treat throat cancer. The success of this therapy could potentially spare patients from undergoing radiotherapy and its associated side effects.

The prevalence of cancer has become a significant factor contributing to the growth of the cell therapy technologies market. Cell therapy, which utilizes living cells as drugs to treat diseases, particularly leverages the immune system's inherent capability to seek out and destroy abnormal cells in the body when applied to cancer treatment. According to the American Cancer Society, it is estimated that the USA will see a total of 1.9 million new cancer cases and 609,360 deaths from cancer in 2022, equating to approximately 1,670 deaths daily. Additionally, projections from the International Agency for Research on Cancer indicate that by 2040, the annual number of new cancer cases is expected to rise to 29.5 million, with cancer-related deaths reaching 16.4 million. The increasing prevalence of cancer cases is anticipated to be a significant driver for the growth of the cell therapy technologies market in the forecast period.

Major companies are focusing on developing innovative products using advanced technologies to achieve growth in the dynamic landscape of the cell therapy technologies market. An illustrative example of this trend is seen in the actions of Invetech, an Australia-based company specializing in the design, engineering, and manufacture of commercial-scale diagnostic products and cell and gene therapies. In June 2022, Invetech launched Korus, a novel closed system for autologous cell therapies. Korus is designed to redefine industry standards in elutriation and cell wash by utilizing a mild elutriation process that provides a cleaner cell population for various cell therapy production processes, such as tumor-infiltrated lymphocytes (TIL), dendritic cells, chimeric antigen receptor (CAR)-T cells, or induced pluripotent stem cell (IPSC)-derived therapy. The technology features elutriation and cell wash using gentle counterflow centrifugation, resulting in purified cell populations for downstream processing development and commercial manufacture. Korus aims to enhance overall process performance through improved recovery and purity of target cells, enabling developers to expedite clinical development and scale-up of their products.

Product innovation remains a key focus in the cell therapy technologies market, with companies striving to develop cutting-edge products to solidify their market positions. In September 2022, denovoMATRIX GmbH, a Germany-based innovator in cell and gene therapy manufacturing, launched animal component-free cell culture product lines at cell therapy grade (CTG). These product lines are equipped with documentation and traceability information to comply with industry regulatory standards, catering to the stem cell therapy manufacturing market. Additionally, in December 2021, Novartis, a Switzerland-based pharmaceutical corporation, introduced T-Charge, its next-generation CAR-T platform. T-Charge serves as the foundation for various new investigational CAR-T cell therapies in the Novartis pipeline. The platform preserves T cell stemness, enhancing proliferative potential and reducing exhausted T cells in the product. With T-Charge, CAR-T cell expansion primarily occurs within a patient's body (in-vivo), eliminating the need for extended culture time outside the body (ex-vivo). These unique characteristics contribute to better and more durable therapeutic responses, improved long-term outcomes, and a reduced risk of severe adverse events.

In July 2022, Evotec, a German biotechnology company, acquired Rigenerand Srl for an undisclosed sum. This acquisition integrates Rigenerand, a cutting-edge cell technology firm specializing in cGMP (current good manufacturing practice) production of cell therapies based in Medolla, Italy, which will now operate under the name Evotec (Modena) Srl. Rigenerand Srl originally hails from Italy and is focused on advanced cell technology.

Major companies operating in the cell therapy technologies market report are Lonza Group AG, Thermo Fisher Scientific Inc., Merck KGaA, Terumo Corporation, Danaher Corporation, Fresenius Medical Care AG & Co. KGaA, Fujifilm Holdings Corporation, Sartorius AG, Becton Dickinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc., Anterogen Co. Ltd., Arce Therapeutics, CARsgen Therapeutics, Huadong Medicine, Co.Don AG, AstraZeneca, Neogene Therapeutics, GammaDelta Therapeutics Limited, Nightstar, SOTIO, Accell Clinical Research, Genestack, Novartis AG, Pfizer, Celgene Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd., Bayer AG, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Amgen Brazil, GlaxoSmithKline PLC, Biogen Brazil, Takeda Pharmaceutical Company Limited, Pfizer S.R.L, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Bayer East Africa Ltd., Adcock Ingram, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies.

North America was the largest region in the cell therapy technologies market in 2023. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the cell therapy technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell therapy technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The cell therapy market consists of sales of cell therapy technologies that are medicinal solutions used for developing and improving cell therapy, such as cell processing, cell banking, and point-of-care technologies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Therapy Technologies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell therapy technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell therapy technologies? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell therapy technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Consumables; Equipment; Systems And Software
• 2) By Cell Type: T-Cells; Stem Cells; Other Cells
• 3) By Process: Cell Processing; Cell Preservation, Distribution And Handling; Process Monitoring And Quality Control
• 4) By End User: Life Science Companies; Research Institutes And Cell Banks
• Companies Mentioned: Lonza Group AG; Thermo Fisher Scientific Inc; Merck KGaA; Terumo Corporation; Danaher Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell Therapy Technologies Market Characteristics

3. Cell Therapy Technologies Market Trends And Strategies

4. Cell Therapy Technologies Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Cell Therapy Technologies Market Size and Growth

• 5.1. Global Cell Therapy Technologies Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Cell Therapy Technologies Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Cell Therapy Technologies Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cell Therapy Technologies Market Segmentation

• 6.1. Global Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Consumables
• Equipment
• Systems & Software
• 6.2. Global Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• T-cells
• Stem Cells
• Other Cells
• 6.3. Global Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Cell Processing
• Cell Preservation, Distribution, and Handling
• Process Monitoring and Quality Control
• 6.4. Global Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Life Science Companies
• Research Institutes

7. Cell Therapy Technologies Market Regional And Country Analysis

• 7.1. Global Cell Therapy Technologies Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Cell Therapy Technologies Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cell Therapy Technologies Market

• 8.1. Asia-Pacific Cell Therapy Technologies Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cell Therapy Technologies Market

• 9.1. China Cell Therapy Technologies Market Overview
• 9.2. China Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cell Therapy Technologies Market

• 10.1. India Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cell Therapy Technologies Market

• 11.1. Japan Cell Therapy Technologies Market Overview
• 11.2. Japan Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cell Therapy Technologies Market

• 12.1. Australia Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cell Therapy Technologies Market

• 13.1. Indonesia Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cell Therapy Technologies Market

• 14.1. South Korea Cell Therapy Technologies Market Overview
• 14.2. South Korea Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cell Therapy Technologies Market

• 15.1. Western Europe Cell Therapy Technologies Market Overview
• 15.2. Western Europe Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cell Therapy Technologies Market

• 16.1. UK Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cell Therapy Technologies Market

• 17.1. Germany Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cell Therapy Technologies Market

• 18.1. France Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cell Therapy Technologies Market

• 19.1. Italy Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cell Therapy Technologies Market

• 20.1. Spain Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cell Therapy Technologies Market

• 21.1. Eastern Europe Cell Therapy Technologies Market Overview
• 21.2. Eastern Europe Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cell Therapy Technologies Market

• 22.1. Russia Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cell Therapy Technologies Market

• 23.1. North America Cell Therapy Technologies Market Overview
• 23.2. North America Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cell Therapy Technologies Market

• 24.1. USA Cell Therapy Technologies Market Overview
• 24.2. USA Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cell Therapy Technologies Market

• 25.1. Canada Cell Therapy Technologies Market Overview
• 25.2. Canada Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cell Therapy Technologies Market

• 26.1. South America Cell Therapy Technologies Market Overview
• 26.2. South America Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cell Therapy Technologies Market

• 27.1. Brazil Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cell Therapy Technologies Market

• 28.1. Middle East Cell Therapy Technologies Market Overview
• 28.2. Middle East Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cell Therapy Technologies Market

• 29.1. Africa Cell Therapy Technologies Market Overview
• 29.2. Africa Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cell Therapy Technologies Market Competitive Landscape And Company Profiles

• 30.1. Cell Therapy Technologies Market Competitive Landscape
• 30.2. Cell Therapy Technologies Market Company Profiles
  • 30.2.1. Lonza Group AG
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Thermo Fisher Scientific Inc
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Merck KGaA
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Terumo Corporation
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Danaher Corporation
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Cell Therapy Technologies Market Other Major And Innovative Companies

• 31.1. Fresenius Medical Care AG & Co. KGaA
• 31.2. Fujifilm Holdings Corporation
• 31.3. Sartorius AG
• 31.4. Becton Dickinson and Company
• 31.5. Avantor Inc.
• 31.6. Cellular Biomedicine Group
• 31.7. CORESTEM
• 31.8. Astellas Pharma Inc
• 31.9. Anterogen Co. Ltd
• 31.10. Arce Therapeutics
• 31.11. CARsgen Therapeutics
• 31.12. Huadong Medicine
• 31.13. Co.Don AG
• 31.14. AstraZeneca
• 31.15. Neogene Therapeutics

32. Global Cell Therapy Technologies Market Competitive Benchmarking

33. Global Cell Therapy Technologies Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cell Therapy Technologies Market

35. Cell Therapy Technologies Market Future Outlook and Potential Analysis

• 35.1 Cell Therapy Technologies Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Cell Therapy Technologies Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Cell Therapy Technologies Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer